<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Hip Knee Book &#187; Fda</title>
	<atom:link href="http://www.hipkneebook.com/tag/fda/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.hipkneebook.com</link>
	<description>Treating Arthritis of the Hip and Knee</description>
	<lastBuildDate>Wed, 08 Feb 2012 21:30:00 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Arthritis and Cholesterol Drugs Well Tolerated in Prostate Cancer Treatment</title>
		<link>http://www.hipkneebook.com/main-content/arthritis-and-cholesterol-drugs-well-tolerated-in-prostate-cancer-treatment/</link>
		<comments>http://www.hipkneebook.com/main-content/arthritis-and-cholesterol-drugs-well-tolerated-in-prostate-cancer-treatment/#comments</comments>
		<pubDate>Tue, 31 Jan 2012 23:40:34 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Arthritis Drugs]]></category>
		<category><![CDATA[Arthritis Pain]]></category>
		<category><![CDATA[Cancer Institute]]></category>
		<category><![CDATA[Cancer Research]]></category>
		<category><![CDATA[Cancer Treatment Research]]></category>
		<category><![CDATA[Celebrex]]></category>
		<category><![CDATA[Cholesterol]]></category>
		<category><![CDATA[Cholesterol Drugs]]></category>
		<category><![CDATA[Clinical Trial]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Fda Approved Drugs]]></category>
		<category><![CDATA[Genitourinary Cancers]]></category>
		<category><![CDATA[Lipitor]]></category>
		<category><![CDATA[Lowering Cholesterol]]></category>
		<category><![CDATA[Phase Ii]]></category>
		<category><![CDATA[Preliminary Results]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[Prostate Cancer Treatment]]></category>
		<category><![CDATA[Recurrent Prostate Cancer]]></category>

		<guid isPermaLink="false">http://www.newswise.com/articles/view/585275/?sc=rsmn</guid>
		<description><![CDATA[Research from The Cancer Institute of New Jersey on the FDA-approved drugs Celebrex(r) and Lipitor(r) -- used respectively for arthritis pain and lowering cholesterol -- shows that these drugs are well tolerated in the treatment of recurrent prostate cancer. Preliminary results from an ongoing Phase II clinical trial will be presented this week during the 2012 Genitourinary Cancers Symposium.]]></description>
			<content:encoded><![CDATA[Research from The Cancer Institute of New Jersey on the FDA-approved drugs Celebrex(r) and Lipitor(r) -- used respectively for arthritis pain and lowering cholesterol -- shows that these drugs are well tolerated in the treatment of recurrent prostate cancer. Preliminary results from an ongoing Phase II clinical trial will be presented this week during the 2012 Genitourinary Cancers Symposium.]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/arthritis-and-cholesterol-drugs-well-tolerated-in-prostate-cancer-treatment/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Action Date for Pfizer&#8217;s Tofacitinib</title>
		<link>http://www.hipkneebook.com/main-content/action-date-for-pfizers-tofacitinib/</link>
		<comments>http://www.hipkneebook.com/main-content/action-date-for-pfizers-tofacitinib/#comments</comments>
		<pubDate>Thu, 22 Dec 2011 20:00:20 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Pfizer]]></category>

		<guid isPermaLink="false">http://finance.yahoo.com/news/action-date-pfizers-tofacitinib-200020333.html</guid>
		<description><![CDATA[With the FDA accepting Pfizer's application for tofacitinib, a response should be out in August 2012.]]></description>
			<content:encoded><![CDATA[With the FDA accepting Pfizer's application for tofacitinib, a response should be out in August 2012.]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/action-date-for-pfizers-tofacitinib/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA accepts application for Pfizer arthritis drug</title>
		<link>http://www.hipkneebook.com/main-content/fda-accepts-application-for-pfizer-arthritis-drug-3/</link>
		<comments>http://www.hipkneebook.com/main-content/fda-accepts-application-for-pfizer-arthritis-drug-3/#comments</comments>
		<pubDate>Wed, 21 Dec 2011 01:34:40 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Adults]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Arthritis Drug]]></category>
		<category><![CDATA[Experimental Drug]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Food And Drug]]></category>
		<category><![CDATA[Food And Drug Administration]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[Pfizer Inc]]></category>
		<category><![CDATA[Rheumatoid Arthritis]]></category>

		<guid isPermaLink="false">http://www.seattlepi.com/business/article/FDA-accepts-application-for-Pfizer-arthritis-drug-2414618.php</guid>
		<description><![CDATA[FDA accepts application for Pfizer arthritis drug NEW YORK (AP) — Drugmaker Pfizer Inc. says the Food and Drug Administration has accepted its application for approval of its experimental drug for adults with moderate to severe rheumatoid arthritis.]]></description>
			<content:encoded><![CDATA[FDA accepts application for Pfizer arthritis drug NEW YORK (AP) — Drugmaker Pfizer Inc. says the Food and Drug Administration has accepted its application for approval of its experimental drug for adults with moderate to severe rheumatoid arthritis.]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/fda-accepts-application-for-pfizer-arthritis-drug-3/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA accepts application for Pfizer arthritis drug</title>
		<link>http://www.hipkneebook.com/main-content/fda-accepts-application-for-pfizer-arthritis-drug-2/</link>
		<comments>http://www.hipkneebook.com/main-content/fda-accepts-application-for-pfizer-arthritis-drug-2/#comments</comments>
		<pubDate>Tue, 20 Dec 2011 20:13:12 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Adults]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Arthritis Drug]]></category>
		<category><![CDATA[Experimental Drug]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Food And Drug]]></category>
		<category><![CDATA[Food And Drug Administration]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[Pfizer Inc]]></category>
		<category><![CDATA[Rheumatoid Arthritis]]></category>

		<guid isPermaLink="false">http://www.sfgate.com/cgi-bin/article.cgi?f=/n/a/2011/12/20/financial/f112901S01.DTL</guid>
		<description><![CDATA[(12-20) 11:29 PST NEW YORK, (AP) -- Drugmaker Pfizer Inc. says the Food and Drug Administration has accepted its application for approval of its experimental drug for adults with moderate to severe rheumatoid arthritis....]]></description>
			<content:encoded><![CDATA[(12-20) 11:29 PST NEW YORK, (AP) -- Drugmaker Pfizer Inc. says the Food and Drug Administration has accepted its application for approval of its experimental drug for adults with moderate to severe rheumatoid arthritis....]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/fda-accepts-application-for-pfizer-arthritis-drug-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA accepts application for Pfizer arthritis drug</title>
		<link>http://www.hipkneebook.com/main-content/fda-accepts-application-for-pfizer-arthritis-drug/</link>
		<comments>http://www.hipkneebook.com/main-content/fda-accepts-application-for-pfizer-arthritis-drug/#comments</comments>
		<pubDate>Tue, 20 Dec 2011 19:29:13 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Adults]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Arthritis Drug]]></category>
		<category><![CDATA[Experimental Drug]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Food And Drug]]></category>
		<category><![CDATA[Food And Drug Administration]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[Pfizer Inc]]></category>
		<category><![CDATA[Rheumatoid Arthritis]]></category>

		<guid isPermaLink="false">http://finance.yahoo.com/news/fda-accepts-application-pfizer-arthritis-192905018.html</guid>
		<description><![CDATA[Drugmaker Pfizer Inc. says the Food and Drug Administration has accepted its application for approval of its experimental drug for adults with moderate to severe rheumatoid arthritis.The FDA says it expects ...]]></description>
			<content:encoded><![CDATA[Drugmaker Pfizer Inc. says the Food and Drug Administration has accepted its application for approval of its experimental drug for adults with moderate to severe rheumatoid arthritis.The FDA says it expects ...]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/fda-accepts-application-for-pfizer-arthritis-drug/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA to review Pfizer rheumatoid arthritis drug</title>
		<link>http://www.hipkneebook.com/main-content/fda-to-review-pfizer-rheumatoid-arthritis-drug/</link>
		<comments>http://www.hipkneebook.com/main-content/fda-to-review-pfizer-rheumatoid-arthritis-drug/#comments</comments>
		<pubDate>Tue, 20 Dec 2011 13:55:16 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Food And Drug]]></category>
		<category><![CDATA[Food And Drug Administration]]></category>
		<category><![CDATA[Health Regulators]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[Pfizer Inc]]></category>
		<category><![CDATA[Regulatory Authorities]]></category>
		<category><![CDATA[Reuters]]></category>
		<category><![CDATA[Rheumatoid Arthritis]]></category>
		<category><![CDATA[Rheumatoid Arthritis Drug]]></category>

		<guid isPermaLink="false">http://news.yahoo.com/fda-review-pfizer-rheumatoid-arthritis-drug-135516046.html</guid>
		<description><![CDATA[(Reuters) - U.S. health regulators have accepted the application for Pfizer Inc's closely watched experimental rheumatoid arthritis drug, the drugmaker said on Tuesday. The Food and Drug Administration is due to decide on the drug, tofacitinib, in August. Pfizer said it has also submitted an application for tofacitinib to regulatory authorities in Japan. Tofacitinib is one of Pfizer's most ...]]></description>
			<content:encoded><![CDATA[(Reuters) - U.S. health regulators have accepted the application for Pfizer Inc's closely watched experimental rheumatoid arthritis drug, the drugmaker said on Tuesday. The Food and Drug Administration is due to decide on the drug, tofacitinib, in August. Pfizer said it has also submitted an application for tofacitinib to regulatory authorities in Japan. Tofacitinib is one of Pfizer's most ...]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/fda-to-review-pfizer-rheumatoid-arthritis-drug/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA accepts Horizon Pharma&#8217;s rheumatoid arthritis drug application</title>
		<link>http://www.hipkneebook.com/main-content/fda-accepts-horizon-pharmas-rheumatoid-arthritis-drug-application/</link>
		<comments>http://www.hipkneebook.com/main-content/fda-accepts-horizon-pharmas-rheumatoid-arthritis-drug-application/#comments</comments>
		<pubDate>Tue, 29 Nov 2011 14:45:21 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Application Developer]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Drug Application]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Food And Drug]]></category>
		<category><![CDATA[Food And Drug Administration]]></category>
		<category><![CDATA[Horizon]]></category>
		<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Rheumatoid Arthritis]]></category>
		<category><![CDATA[Rheumatoid Arthritis Drug]]></category>
		<category><![CDATA[Rheumatoid Arthritis Treatment]]></category>

		<guid isPermaLink="false">http://www.chicagotribune.com/business/breaking/chi-fda-accepts-horizon-pharmas-rheumatoid-arthritis-drug-application-20111129,0,6035557.story?track=rss</guid>
		<description><![CDATA[Arthritis-treatment developer Horizon Pharma Inc. said Tuesday that the Food and Drug Administration has accepted its application for the rheumatoid arthritis treatment Lodotra and plans to make a decision on the drug by July 26.]]></description>
			<content:encoded><![CDATA[Arthritis-treatment developer Horizon Pharma Inc. said Tuesday that the Food and Drug Administration has accepted its application for the rheumatoid arthritis treatment Lodotra and plans to make a decision on the drug by July 26.]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/fda-accepts-horizon-pharmas-rheumatoid-arthritis-drug-application/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA accepts Horizon Pharma&#8217;s Lodotra application</title>
		<link>http://www.hipkneebook.com/main-content/fda-accepts-horizon-pharmas-lodotra-application/</link>
		<comments>http://www.hipkneebook.com/main-content/fda-accepts-horizon-pharmas-lodotra-application/#comments</comments>
		<pubDate>Tue, 29 Nov 2011 14:08:39 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Application Developer]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Food And Drug]]></category>
		<category><![CDATA[Food And Drug Administration]]></category>
		<category><![CDATA[Horizon]]></category>
		<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Rheumatoid Arthritis]]></category>
		<category><![CDATA[Rheumatoid Arthritis Treatment]]></category>

		<guid isPermaLink="false">http://news.yahoo.com/fda-accepts-horizon-pharmas-lodotra-application-140839076.html</guid>
		<description><![CDATA[Arthritis-treatment developer Horizon Pharma Inc. said Tuesday that the Food and Drug Administration has accepted its application for the rheumatoid arthritis treatment Lodotra and plans to make a decision on the drug by July 26.]]></description>
			<content:encoded><![CDATA[Arthritis-treatment developer Horizon Pharma Inc. said Tuesday that the Food and Drug Administration has accepted its application for the rheumatoid arthritis treatment Lodotra and plans to make a decision on the drug by July 26.]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/fda-accepts-horizon-pharmas-lodotra-application/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Roche Wins Broader U.S. FDA Approval for Arthritis Treatment Actemra</title>
		<link>http://www.hipkneebook.com/main-content/roche-wins-broader-u-s-fda-approval-for-arthritis-treatment-actemra/</link>
		<comments>http://www.hipkneebook.com/main-content/roche-wins-broader-u-s-fda-approval-for-arthritis-treatment-actemra/#comments</comments>
		<pubDate>Wed, 05 Jan 2011 17:50:08 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Actemra]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Arthritis Treatment]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Fda Approval]]></category>
		<category><![CDATA[Medicine]]></category>
		<category><![CDATA[Rheumatoid Arthritis]]></category>
		<category><![CDATA[Roche Holding Ag]]></category>
		<category><![CDATA[Wins]]></category>

		<guid isPermaLink="false">http://www.bloomberg.com/news/2011-01-05/roche-wins-broader-u-s-fda-approval-for-arthritis-treatment-actemra.html</guid>
		<description><![CDATA[Roche Holding AG ’s Actemra medicine won expanded U.S. approval as a treatment for moderate to severe rheumatoid arthritis.]]></description>
			<content:encoded><![CDATA[Roche Holding AG ’s Actemra medicine won expanded U.S. approval as a treatment for moderate to severe rheumatoid arthritis.]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/roche-wins-broader-u-s-fda-approval-for-arthritis-treatment-actemra/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Arthritis Foundation Patient Advocate to Testify at FDA Hearing on Approval Pathway for Biosimilars</title>
		<link>http://www.hipkneebook.com/main-content/arthritis-foundation-patient-advocate-to-testify-at-fda-hearing-on-approval-pathway-for-biosimilars/</link>
		<comments>http://www.hipkneebook.com/main-content/arthritis-foundation-patient-advocate-to-testify-at-fda-hearing-on-approval-pathway-for-biosimilars/#comments</comments>
		<pubDate>Tue, 02 Nov 2010 14:14:44 +0000</pubDate>
		<dc:creator>Content Keyword RSS</dc:creator>
				<category><![CDATA[Main Content]]></category>
		<category><![CDATA[Arthritis]]></category>
		<category><![CDATA[Arthritis Foundation]]></category>
		<category><![CDATA[Biologic Products]]></category>
		<category><![CDATA[Challenges]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Fda Approval]]></category>
		<category><![CDATA[Focus]]></category>
		<category><![CDATA[Food And Drug]]></category>
		<category><![CDATA[Food And Drug Administration]]></category>
		<category><![CDATA[Food And Drug Administration Fda]]></category>
		<category><![CDATA[Inflammatory Arthritis]]></category>
		<category><![CDATA[Nov 2]]></category>
		<category><![CDATA[Oral Testimony]]></category>
		<category><![CDATA[Pathway]]></category>
		<category><![CDATA[Patient Advocate]]></category>
		<category><![CDATA[Phd]]></category>

		<guid isPermaLink="false">http://www.redorbit.com/news/health/1942226/arthritis_foundation_patient_advocate_to_testify_at_fda_hearing_on/index.html?source=r_health</guid>
		<description><![CDATA[ATLANTA, Nov. 2, 2010 /PRNewswire-USNewswire/ -- Arthritis Foundation patient advocate, Jan Wyatt, PhD, will provide oral testimony on behalf of the approximately 4 million Americans with inflammatory arthritis at a Food and Drug Administration (FDA) hearing today. The hearing will focus on issues and challenges associated with an approval pathway for biologic products that are highly similar ...]]></description>
			<content:encoded><![CDATA[ATLANTA, Nov. 2, 2010 /PRNewswire-USNewswire/ -- Arthritis Foundation patient advocate, Jan Wyatt, PhD, will provide oral testimony on behalf of the approximately 4 million Americans with inflammatory arthritis at a Food and Drug Administration (FDA) hearing today. The hearing will focus on issues and challenges associated with an approval pathway for biologic products that are highly similar ...]]></content:encoded>
			<wfw:commentRss>http://www.hipkneebook.com/main-content/arthritis-foundation-patient-advocate-to-testify-at-fda-hearing-on-approval-pathway-for-biosimilars/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

